Development and validation of a dissolution test for lodenafil carbonate based on in vivo data. (April 2014)
- Record Type:
- Journal Article
- Title:
- Development and validation of a dissolution test for lodenafil carbonate based on in vivo data. (April 2014)
- Main Title:
- Development and validation of a dissolution test for lodenafil carbonate based on in vivo data
- Authors:
- Codevilla, Cristiane Franco
Castilhos, Tamara dos Santos
Cirne, Carolina Araújo
Froehlich, Pedro Eduardo
Bergold, Ana Maria - Abstract:
- <abstract> <title>Abstract</title> <p> <italic>Introduction</italic>: Lodenafil carbonate is a phosphodiesterase type 5 inhibitor used for the treatment of erectile dysfunction. Currently, there is no dissolution test reported for lodenafil carbonate and this drug is not listed in any pharmacopoeia.</p> <p> <italic>Objective</italic>:<italic></italic>The present study focused on the development and validation of a dissolution test for lodenafil carbonate tablets, using a simulated absorption profile based on <italic>in vivo</italic> data.</p> <p> <italic>Methods</italic>: The appropriate conditions were determined after testing sink conditions. Different conditions as medium, surfactant concentration and rotation speed were evaluated. The percentage of dose absorbed was calculated by deconvolution, using the Wagner–Nelson method.</p> <p> <italic>Results</italic>: According to the obtained results, the use of 0.1 M HCl + 1.5% SLS (900 mL, at 37 + 0.5 °C) as the dissolution medium, paddles at 25 rpm were considered adequate. The samples were quantified by UV spectroscopy at 295 nm and the validation was performed according to international guidelines. The method showed specificity, linearity, accuracy and precision, within the acceptable range. Kinetics of drug release was better described by the first-order model.</p> <p> <italic>Conclusion</italic>: The proposed dissolution test can be used for the routine quality control of lodenafil carbonate in tablets.</p> </abstract>
- Is Part Of:
- Drug development and industrial pharmacy. Volume 40:Number 4(2014:Apr.)
- Journal:
- Drug development and industrial pharmacy
- Issue:
- Volume 40:Number 4(2014:Apr.)
- Issue Display:
- Volume 40, Issue 4 (2014)
- Year:
- 2014
- Volume:
- 40
- Issue:
- 4
- Issue Sort Value:
- 2014-0040-0004-0000
- Page Start:
- 488
- Page End:
- 493
- Publication Date:
- 2014-04
- Subjects:
- Pharmaceutical chemistry -- Periodicals
Pharmaceutical industry -- Periodicals
Drug Industry -- Periodicals
Technology, Pharmaceutical -- Periodicals
615.05 - Journal URLs:
- http://informahealthcare.com/loi/ddi ↗
http://informahealthcare.com ↗ - DOI:
- 10.3109/03639045.2013.768633 ↗
- Languages:
- English
- ISSNs:
- 0363-9045
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3629.116000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 3461.xml